🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss — March 2026 Page 4

Semaglutide cardiovascular benefit independent of weight loss — March 2026

KevinCompounds Wed, Sep 11, 2024 at 8:02 PM 50 replies 2,983 viewsPage 4 of 10
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Sep 12, 2024 at 1:42 AM#16

Just wanted to say — for anyone reading this Semaglutide thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Sep 12, 2024 at 6:42 AM
7 21JakeSmashed95, NauseaFreeNow, SteveThurs and 4 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Sep 12, 2024 at 1:59 AM#17

KevinCompounds's experience with Semaglutide resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 50 lbs in 5 months.

One thing I would add that KevinCompounds did not mention: the mental health improvements were just as significant.

Last edited: Sep 12, 2024 at 4:59 AM
50 10LarryQC_SD, wanda_boise, NurseAsh_DET and 47 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Sep 12, 2024 at 2:16 AM#18

Saving this for reference. Top-tier content.

16 1adam_van, Dr.SurgeonPGH, rachel_ABQ and 13 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Sep 12, 2024 at 2:33 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Semaglutide cardiovascular benefit.

Building on what KevinCompounds said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
44 16tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 41 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Sep 12, 2024 at 2:50 AM#20

Subscribing to this thread. Semaglutide is exactly what I've been researching. 🙏

7 14LindaRN_retired, tommy_boulder, hyun_seoul and 4 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register